SELP and cancer: Notably, whether lung cancer patients were taking any type of antiplatelet or anticoagulant drug did not influence PTCA formation nor P-selectin expression within PTCAs (not shown), indicating that PTCA formation may provide clinically useful insight with respect to cancer and thrombosis risk, including recurrent thrombosis.